Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9503]

SABCS 2025: Latest developments in multigene testing in early breast cancer

Prof Nadia Harbeck and Prof Giuseppe Curigliano

SABCS 2025: Latest developments in multigene testing in early breast cancer ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )

Gustave Roussy International Egypt: Public private partnership model in cancer...

Dr Ahmed Hassan Abdel Aziz, Dr Yasmine El Hennawii & Dr Nermeen Moustafa

Gustave Roussy International Egypt: Public private partnership model in cancer care ( Dr Ahmed Hassan Abdel Aziz, Dr Yasmine El Hennawii & Dr Nermeen Moustafa )

Multimodal AI model augments Oncotype DX in predicting distant recurrence in...

Dr Joseph Sparano - Icahn School of Medicine at Mount Sinai, New York, USA

Multimodal AI model augments Oncotype DX in predicting distant recurrence in HR+/HER2 node negative BC ( Dr Joseph Sparano - Icahn School of Medicine at Mount Sinai, New York, USA )

Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL...

Prof Hisham Abdel-Azim - Loma Linda University, Loma Linda, USA

Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL undergoing allogeneic HCT ( Prof Hisham Abdel-Azim - Loma Linda University, Loma Linda, USA )

Higher tumour-infiltrating lymphocytes predict better pathologic response in...

Prof Sunil Badve - Emory University, Atlanta, USA

Higher tumour-infiltrating lymphocytes predict better pathologic response in HER2-positive breast cancer ( Prof Sunil Badve - Emory University, Atlanta, USA )

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in...

Dr Anjali Advani - Cleveland Clinic, Cleveland, USA

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in elderly patients with Ph+ ALL ( Dr Anjali Advani - Cleveland Clinic, Cleveland, USA )

Blinatumomab plus chemotherapy shows manageable toxicity in adults with Ph- B...

Dr Anjali Advani - Cleveland Clinic, Cleveland, USA

Blinatumomab plus chemotherapy shows manageable toxicity in adults with Ph- B-ALL ( Dr Anjali Advani - Cleveland Clinic, Cleveland, USA )

Tucatinib added to trastuzumab and pertuzumab improves PFS in first-line HER2...

Dr Erika Hamilton - Sarah Cannon Research Institute, Nashville, USA

Tucatinib added to trastuzumab and pertuzumab improves PFS in first-line HER2-positive metastatic breast cancer ( Dr Erika Hamilton - Sarah Cannon Research Institute, Nashville, USA )

Oncofertility counseling and fertility preservation in premenopausal women with...

Dr Matteo Lambertini - University of Genova, Genova, Italy

Oncofertility counseling and fertility preservation in premenopausal women with early breast cancer ( Dr Matteo Lambertini - University of Genova, Genova, Italy )

Aromatase inhibitors improve disease-free survival in HR+/HER2+ early breast...

Dr Matteo Lambertini - University of Genova, Genova, Italy

Aromatase inhibitors improve disease-free survival in HR+/HER2+ early breast cancer: ALTTO 10-year follow-up ( Dr Matteo Lambertini - University of Genova, Genova, Italy )

Sacituzumab govitecan improves quality of life in untreated advanced TNBC

Dr Kevin Punie - Ziekenhuis aan de Stroom, Antwerp, Belgium

Sacituzumab govitecan improves quality of life in untreated advanced TNBC ( Dr Kevin Punie - Ziekenhuis aan de Stroom, Antwerp, Belgium )

Pirtobrutinib significantly improves PFS in treatment-naïve CLL/SLL compared to...

Prof Wojciech Jurczak - Maria Sklodowska-Curie National Research Institute of...

Pirtobrutinib significantly improves PFS in treatment-naïve CLL/SLL compared to bendamustine plus rituximab ( Prof Wojciech Jurczak - Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland )

More from ecancer